The National Hybrid Closed Loop and Type 1 Diabetes Outpatient Transformation Programme

Health Innovation East is leading the delivery of the National Hybrid Closed Loop (HCL) and Type 1 Diabetes Outpatient Transformation Programme across the East of England, working closely with the regional NHS England team, Integrated Care Boards, provider organisations and clinical teams to support local implementation.

The National Hybrid Closed Loop (HCL) and Type 1 Diabetes Outpatient Transformation Programme is supporting the NHS to improve outcomes for people living with type 1 diabetes by increasing access to Hybrid Closed Loop technology. The programme is led by Health Innovation Network South London and NHS England, working in partnership with the regional Health Innovation Networks, Integrated Care Boards (ICBs), NHS providers and clinical teams across England.

Why this work matters

Around 267,000 people in England are living with type 1 diabetes, a lifelong autoimmune condition that requires continuous insulin therapy and regular blood glucose monitoring (1). Managing the condition can place a significant daily burden on individuals and families, while poor glucose control increases the risk of serious long-term complications, including cardiovascular disease, kidney disease and vision loss.

Hybrid Closed Loop technology combines continuous glucose monitoring with automated insulin delivery to help people maintain blood glucose levels within target range. Evidence shows that HCL systems can improve glucose control, reduce the risk of diabetes-related complications and lessen the day-to-day demands of managing the condition, helping people to live healthier and more independent lives (2).

The national programme builds on the implementation of NICE Technology Appraisal TA943, supporting equitable adoption of HCL technology while using the opportunity to redesign outpatient diabetes services to deliver more personalised, efficient and sustainable care (3).

Health Innovation East's role

Health Innovation East is leading delivery of the programme across the East of England, working closely with the regional NHS England team, Integrated Care Boards, provider organisations and clinical teams to support local implementation.

The programme focuses on two key priorities:

  • increasing equitable access to Hybrid Closed Loop technology by helping NHS organisations to make best use of current reimbursement models and plan for long term delivery,
  • using HCL implementation as a catalyst to transform outpatient diabetes care.

Working collaboratively with our local NHS England network, Health Innovation East is developing a regional programme of activities. Health Innovation East will also work with regional and national partners to monitor implementation, share learning and evaluate the programme’s impact as it progresses.

Regional HCL Diabetes Transformation Workshop – PIFU and Outpatient Innovation [In-person event] 18 September 2026

Delivered by the East of England Diabetes Clinical Network, in collaboration with Health Innovation East.

Date: Friday 18 September 2026

Time: 10:00am – 3:00pm

Venue: Bevan Room, Victoria House, CB21 5XA

To register, please click here

As the HCL Diabetes Transformation Programme enters Year 3 of 5, this interactive event will bring together consultants, clinical leads, diabetes specialist nurses, outpatient leads and transformation leads to explore how services can adapt to increasing demand, improve patient experience and support more sustainable outpatient models.

The workshop is intended for diabetes clinical leads, consultant diabetologists, diabetes specialist nurses, service and operational leads, transformation leads, HCL programme colleagues and other healthcare professionals involved in diabetes service delivery, outpatient transformation and pathway redesign across the East of England.

Find out more

Share your idea

Do you have a great idea that could deliver meaningful change in the real world?

Get involved

Newsletter